The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...
While multi-indication bispecific therapies are likely to expand in lymphoma, their use must remain driven by efficacy, with ...
For most of her life, Sarah Eberle was sure of her path: she was a wife, a friend, and a nurse at Huntsville Hospital.
The Winfield boys basketball team cheered for one of their own Friday night during their first home game. 16-year-old ...
Suleika Jaouad's leukemia experience highlights the importance of mindfulness and support networks in managing the disease.
Developing slowly over months to years, feline small cell gastrointestinal (GI) lymphoma can be difficult to detect. 1 With this type of cancer resembling many of the common digestive issues cats ...
Incyte (INCY) stock and Xencor (XNCR) stock are in focus as jointly developed antibody drug tafasitamab succeeds in a ...
Larry Vandersall has defied medical odds for nearly a decade. His secret? Faith, family, and an unshakeable positive attitude ...
Chicago’s Very Own Derrick Rose surprised 15-year-old Delvin McGee during a visit to the Bulls’ practice facility Friday ...
Effective Sjögren’s management demands a strict separation between symptomatic relief for sicca and immunosuppression for ...
The trial met its primary endpoint with a hazard ratio of 0.75, indicating a significant reduction in disease progression ...
A positive top-line readout from a phase 3 trial has emboldened Incyte to seek the FDA’s blessing for the company’s Monjuvi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results